What one share of Integrated Biopharma holds
Integrated Biopharma’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.41 |
|---|---|
| Profit | −$0.09 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | $0.03 |
| Cash and investments | $0.14 |
| Book value | $0.57 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | $1.96 | −$0.11 | $0.01 | $0.00 | — | −$0.37 |
| 2012 | $1.74 | −$0.13 | $0.01 | −$0.04 | — | −$0.49 |
| 2013 | $1.58 | $0.00 | $0.00 | −$0.07 | — | −$0.49 |
| 2014 | $1.59 | $0.01 | $0.01 | $0.08 | — | −$0.48 |
| 2015 | $1.28 | $0.03 | $0.01 | −$0.01 | — | −$0.44 |
| 2016 | $1.99 | $0.05 | $0.01 | −$0.03 | — | −$0.39 |
| 2017 | $2.00 | $0.10 | $0.01 | $0.00 | — | −$0.28 |
| 2018 | $1.44 | $0.02 | $0.01 | $0.03 | — | −$0.25 |
| 2019 | $1.69 | $0.06 | $0.01 | −$0.00 | — | $0.06 |
| 2020 | $1.69 | $0.13 | $0.01 | $0.04 | — | $0.20 |
| 2021 | $1.98 | $0.25 | $0.01 | $0.09 | — | $0.48 |
| 2022 | $1.74 | $0.12 | $0.01 | $0.11 | — | $0.62 |
| 2023 | $1.69 | −$0.00 | $0.00 | $0.04 | — | $0.63 |
| 2024 | $1.63 | $0.00 | $0.02 | $0.01 | — | $0.64 |
| 2025 | $1.74 | $0.03 | $0.01 | $0.06 | — | $0.65 |
| 2026 | $1.41 | −$0.09 | $0.01 | $0.03 | — | $0.57 |
Common questions about Integrated Biopharma
How much does one share of Integrated Biopharma earn?
Over its latest fiscal year, Integrated Biopharma lost $0.09 for each share on $1.41 of sales.
Does Integrated Biopharma pay a dividend?
Integrated Biopharma didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Integrated Biopharma’s book value per share?
Integrated Biopharma’s book value is $0.57 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Integrated Biopharma have?
Each share of Integrated Biopharma has $0.14 of cash and investments, as of June 30, 2026.
What is Integrated Biopharma’s free cash flow per share?
$0.03 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has Integrated Biopharma bought back shares?
Integrated Biopharma’s share count rose about 49% from 2011 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.